InvivoGen
InvivoGen was founded in 1997 by scientists with technical expertise and creative excellence stemming from a longstanding history in microbiology. InvivoGen's unparalleled skill in microbial fermentation enables them to provide a wide range of biological molecules, including ultra-pure antibiotics, novel mycoplasma treatments and the largest collection of pattern recognition receptor agonists derived from a wide range of micro-organisms.
More information at https://www.invivogen.com.
InvivoGen
Non-fucosylated human IgG1 monoclonal antibody against human CTLA-4 (ipilimumab)
InvivoGen
Recombinant monoclonal human IgG1 antibody against IL-6R (Tocilizumab)
InvivoGen
Recombinant monoclonal human IgG1NQ antibody against IL-6R (Tocilizumab)
InvivoGen
Recombinant monoclonal human IgA2 antibody against IL-6R (Tocilizumab)
InvivoGen
Monoclonal IgG1 positive control for class I Luminex® (LABScreen® or LIFECODES HLA)
InvivoGen
Monoclonal IgG1 positive control for class II Luminex® (LABScreen® or LIFECODES HLA)